Description
The DLin-MC3 LNP formulation, containing firefly luciferase mRNA, is developed using a standard LNP formulation with the key ionizable lipid DLin-MC3. The cargo, Fluc (N1meψ) mRNA, has undergone full modification of all U bases with N1-methyl-pseudo-uridine. Upon translation, Fluc (N1meψ) mRNA generates firefly luciferase, which emits bioluminescence upon interacting with its substrate, Luciferin. This mRNA sequence is widely employed as a fluorescence reporter in mRNA therapeutics and delivery system development endeavors. This formulation acts as a reliable control for evaluating the suitability of the DLin-MC3 LNP formulation for your mRNA product in both in vitro and in vivo experiments.
| Gene name | Fluc (N1meψ) |
|---|---|
| LNP ionizable lipid | DLin-MC3 |
| Concentration | 0.2 mg/mL |
| Storage Buffer | 5% Sucrose in PBS |
| ORF length (bp) | 1653 |
| mRNA Molecular Weight (kDa) | 758 |
| Storage Temperature | -80°C |
| Shipping Condition | Dry ice |
| Handling | Avoid freeze and thaw |
| Appearance | Clear and colorless |
| Purity | Fragment analysis by capillary electrophoresis |
| Base Composition | N1meψ |
| Capping | Cap1 |
| Stock | In stock |
